SUMMARY The aim of this study was to characterise new users of hormonal replacement therapy (HRT) for the relief of menopausal symptoms and to compare these women with never-users of HRT; 402 new users and 804 never-users were studied. Hot flushes were the most common symptom in both users and non-users and were the most frequent reason for prescribing HRT. The prevalence of menopausal symptoms in non-users of HRT was high although substantially lower than that in users. HRT users were more likely to be current cigarette smokers than were never-users. There was also, within smokers, a significant relation between the number of cigarettes smoked and the likelihood of using HRT. This relation between HRT use and smoking could result from an anti-oestrogen effect of smoking, intensifying menopausal symtoms. Of potential clinical relevance is the suggestion that a proportion of women using HRT may be doing so in order to alleviate smoking-induced symptoms. Users of HRT were also more likely to have used oral contraceptives than were never-users; this relation was probably behavioural.
Several epidemiological studies have assessed the relation between HRT use and the risks of death, coronary heart disease, or stroke. In some, the effect of HRT has been assessed as protective,1 2 in another3 as a risk factor, and in others [4] [5] [6] [7] HRT has appeared to have no effect. Most ofthis published work is based on studies of women in the USA. An investigation of the relation between HRT use and the subsequent development of stroke or myocardial infarction based on United Kingdom data and relevant to the current picture of HRT prescribing in general practice is therefore of obvious interest, and a case-control study is in progress in this unit. The study comparing HRT users with never-users presented here was designed to provide information about possible confounding factors. An unexpected finding of the study is the indirect suggestion that many women using HRT may be doing so in order to alleviate smoking-induced symptoms.
Methods

PARTICIPANTS
The study was Users were more likely to be current smokers than were controls (odds ratio= 1 -46, p = 0005) (tables 1 and 3 (a)), and to smoke more than controls (table 3 (b)). Within smokers, there was a strong relation between HRT use and the number of cigarettes smoked (p =0009). There was no relation between ex-smoking and HRT use. Multiple regression analysis showed that the two associations, between HRT use and current smoking, and between HRT and oral contraceptive use, were independent of one another. The prevalence of menopausal symptoms in smokers was greater than that in non-smokers (table 4) . Stepwise multiple regression analysis using number of cigarettes currently smoked and Gillian Greenberg, S G Thompson, and T W Meade a dose-response relation. Both explanations may apply. It is also possible that there may be a group of women predisposed by some unidentified factor (for example, behavioural characteristics) to both smoking and the use of HRT. Here, too, the relation would need to be very strong to result in a dose-response effect. Doctors may be more ready to prescribe HRT for smokers than for non-smokers in an attempt to reduce smoking-associated osteoporosis,12 15-17 but it is unlikely that this consideration affected prescribing practice. It seems more probable that a proportion of women using HRT are doing so in order to alleviate smoking-induced symptoms.
